21 related articles for article (PubMed ID: 3767072)
1. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
Ranft J; Heidrich H; Lammersen T
J Mal Vasc; 1987; 12(1):78-81. PubMed ID: 3559415
[TBL] [Abstract][Full Text] [Related]
2. [Naftidrofuryl in stages III and IV of peripheral arterial occlusive disease].
Horsch S
Vasa Suppl; 1988; 24():38-43. PubMed ID: 3212602
[No Abstract] [Full Text] [Related]
3. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
4. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
Pohle W; Hirche H; Barmeyer J; Schümichen C; Hoffmann G
Med Welt; 1979 Feb; 30(7):269-72. PubMed ID: 372733
[No Abstract] [Full Text] [Related]
5. [Effect of intravenous naftidrofuryl on the microcirculation of patients in stages III and IV of arterial occlusive disease].
Abendroth D; Sunder-Plassmann L
Vasa Suppl; 1988; 24():33-7. PubMed ID: 3212601
[No Abstract] [Full Text] [Related]
6. Clinical information content of transcutaneous oxymetry (tcpO2) in peripheral arterial occlusive disease (a review of the methodological and clinical literature with a special reference to critical limb ischaemia).
Scheffler A; Rieger H
Vasa; 1992; 21(2):111-26. PubMed ID: 1621428
[TBL] [Abstract][Full Text] [Related]
7. [Transcutaneous oxygen pressure (TcPO2): advantages and limitations].
Got I
Diabetes Metab; 1998 Sep; 24(4):379-84. PubMed ID: 9805653
[TBL] [Abstract][Full Text] [Related]
8. tcpO2, arterial blood flow and lactate/pyruvate modifications induced by a single dose of naftidrofuryl IV during stage III lower-limb arteriopathies.
Pointel JP; Thomas C; Mosnier M; Percebois G; Debry G
Angiology; 1986 Sep; 37(9):647-53. PubMed ID: 3767072
[TBL] [Abstract][Full Text] [Related]
9. Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
Barradell LB; Brogden RN
Drugs Aging; 1996 Apr; 8(4):299-322. PubMed ID: 8920176
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
